Nanosonics Limited (Nanosonics) is a publicly held company, specialized in developing infection control solutions for the global healthcare market. Its products are marketed under the brand, Trophon. The company`s initial products are chiefly designed to reprocess reusable medical instruments. The intellectual property owned by the company is related to a unique disinfection and sterilization technology that holds various core benefits compared to existing technologies. Its exclusive disinfection and sterilization technologies offersd the unique ability for the production of safe, non-toxic and rapid infection control solutions to various markets. Nanosonic`s products Trophon EPR is a device designed specifically to disinfect intracavity and surface ultrasound probes. The company is headquartered at Alexandria in New South Wales, Australia.The company reported revenues of (Australian Dollars) AUD 1.65 million during the fiscal year ended June 2009, a decrease of 45.89% from 2008. The operating loss of the company was AUD 8.75 million during the fiscal year 2009, as compared to an operating loss of AUD 7.15 million during 2008. The net loss of the company was AUD 8.75 million during the fiscal year 2009, as compared to a net loss of AUD 7.15 million during 2008.